OBJECTIVE: To evaluate the utility of immunohistochemical stains for desmin in discriminating mesothelial cells from adenocarcinoma in serous fluid cell block preparations. STUDY DESIGN: Cell block preparations from 22 cases (representing 18 patients) that were positive for carcinoma and 5 cases that were negative for malignancy were immunostained with an antibody to desmin. Positive staining was evaluated and scored semiquantitatively in both tumor cells and background mesothelial cells in the malignant cases and mesothelial cells in the negative controls. Staining was evaluated with a score of 0-3 for intensity and 0-5 for distribution. The sum of the two scores was recorded as the total score (TS). RESULTS: Mesothelial cells from all the...
Mesothelial cells covering the serous membranes are of mesodermal origin although they acquire sever...
Objective: To evaluate the utility of claudin-4 as a pan-carcinoma marker in cell-blocks of effusion...
Objective The aim of this study was to investigate the utility of BRCA1-associated protein-1 (BAP1),...
Contains fulltext : 69807.pdf (publisher's version ) (Closed access)OBJECTIVE: To ...
BACKGROUND: The distinction of benign from malignant mesothelial proliferations in cytologic specim...
Introduction: Although cytological examination helps in diagnosis of malignancy in serous effusion, ...
Abstract Background and Objective: Identification of malignant cells and the type of malignancy in ...
To determine the utility of immunohistochemical staining for p53 in cell block material for distingu...
Background: The cytological diagnoses of serous effusions are usually made by routine cytomorphology...
OBJECTIVE: To determine the diagnostic value of the BCA-225 antibody in discriminating adenocarcinom...
OBJECTIVE: To analyze the role of immunochemistry in serous effusions.STUDY DESIGN: We analyzed cell...
Background: Malignant mesothelioma (MM) carries a poor prognosis and response rates to palliative ch...
OBJECTIVE: Traditionally, the diagnosis of pleural mesothelioma is based on histological material. M...
OBJECTIVE: To determine the proliferation rates of mesothelial cells in metastatic and benign effusi...
Background: The cytological examination of serous body effusions to diagnose and stage malignancy is...
Mesothelial cells covering the serous membranes are of mesodermal origin although they acquire sever...
Objective: To evaluate the utility of claudin-4 as a pan-carcinoma marker in cell-blocks of effusion...
Objective The aim of this study was to investigate the utility of BRCA1-associated protein-1 (BAP1),...
Contains fulltext : 69807.pdf (publisher's version ) (Closed access)OBJECTIVE: To ...
BACKGROUND: The distinction of benign from malignant mesothelial proliferations in cytologic specim...
Introduction: Although cytological examination helps in diagnosis of malignancy in serous effusion, ...
Abstract Background and Objective: Identification of malignant cells and the type of malignancy in ...
To determine the utility of immunohistochemical staining for p53 in cell block material for distingu...
Background: The cytological diagnoses of serous effusions are usually made by routine cytomorphology...
OBJECTIVE: To determine the diagnostic value of the BCA-225 antibody in discriminating adenocarcinom...
OBJECTIVE: To analyze the role of immunochemistry in serous effusions.STUDY DESIGN: We analyzed cell...
Background: Malignant mesothelioma (MM) carries a poor prognosis and response rates to palliative ch...
OBJECTIVE: Traditionally, the diagnosis of pleural mesothelioma is based on histological material. M...
OBJECTIVE: To determine the proliferation rates of mesothelial cells in metastatic and benign effusi...
Background: The cytological examination of serous body effusions to diagnose and stage malignancy is...
Mesothelial cells covering the serous membranes are of mesodermal origin although they acquire sever...
Objective: To evaluate the utility of claudin-4 as a pan-carcinoma marker in cell-blocks of effusion...
Objective The aim of this study was to investigate the utility of BRCA1-associated protein-1 (BAP1),...